G
Giovanni F.M. Strippoli
Researcher at University of Sydney
Publications - 318
Citations - 19179
Giovanni F.M. Strippoli is an academic researcher from University of Sydney. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 71, co-authored 298 publications receiving 16385 citations. Previous affiliations of Giovanni F.M. Strippoli include University of Catania & University of Eastern Piedmont.
Papers
More filters
Journal ArticleDOI
Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
TL;DR: Meta-analyses and clinical trial data on the therapeutic options for proliferative lupus nephritis are reviewed, and a meta-analysis of the use of mycophenolate mofetil (MMF) compared with cyclophosphamide-based regimens is complete.
Journal ArticleDOI
Depression and all-cause and cardiovascular mortality in patients on haemodialysis: a multinational cohort study
Valeria Saglimbene,Suetonia C. Palmer,Marco Scardapane,Jonathan C. Craig,Marinella Ruospo,Patrizia Natale,Letizia Gargano,Miguel Leal,Anna Bednarek-Skublewska,Jan Duława,Tevfik Ecder,Paul Stroumza,Angelo M. Murgo,Staffan Schön,Charlotta Wollheim,Jörgen Hegbrant,Giovanni F.M. Strippoli +16 more
TL;DR: The association between depression and cardiovascular mortality in adults with kidney failure treated with haemodialysis is uncertain and may only be a risk factor for premature death when at least of moderate severity.
Journal ArticleDOI
The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review.
Suetonia C. Palmer,Marinella Ruospo,Armando Teixeira-Pinto,Jonathan C. Craig,Petra Macaskill,Giovanni F.M. Strippoli,Giovanni F.M. Strippoli +6 more
TL;DR: The association between antihypertensive drug effects on doubling of serum creatinine level and albuminuria or proteinuria with ESKD in treatment trials is not sufficiently certain to enable the confident use of these markers to guide clinical or regulatory decision making.
Journal ArticleDOI
Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis
Suetonia C. Palmer,Marinella Ruospo,Germaine Wong,Jonathan C. Craig,Massimo Petruzzi,Michele De Benedittis,Pauline J. Ford,David W. Johnson,David W. Johnson,Marcello Tonelli,Patrizia Natale,Valeria Saglimbene,Fabio Pellegrini,Eduardo Celia,Ruben Gelfman,Miguel Leal,Marietta Török,Paul Stroumza,Luc Frantzen,Anna Bednarek-Skublewska,Jan Duława,Domingo Del Castillo,Amparo G. Bernat,Jörgen Hegbrant,Charlotta Wollheim,Staffan Schön,Letizia Gargano,Casper P. Bots,Giovanni F.M. Strippoli +28 more
TL;DR: Oral disease in adults on hemodialysis is very common, frequently severe and highly variable among countries, with much of the variability unexplained by participant characteristics or healthcare.
Journal ArticleDOI
Proteinuria and clinical outcomes in hypertensive patients.
TL;DR: Economic evaluations of these interventions confirm their cost-saving benefits relative to other antihypertensives, but outcomes-based research is needed in some settings.